The use of incretin agents and risk of acute and chronic pancreatitis: a population ‐based cohort study
ConclusionsIncretin use was associated with an increased risk of any pancreatitis. Moreover, risk of any and acute pancreatitis was higher when applying a new user design. We could not detect an association with chronic pancreatitis, but numbers in this subgroup were small.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Lotte M. Knapen, Roy G.P.J. de Jong, Johanna H.M. Driessen, Yolande C. Keulemans, Nielka P. van Erp, Marie L. De Bruin, Hubert G.M. Leufkens, Sander Croes, Frank de Vries Tags: ORIGINAL ARTICLE Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Incretin Therapy | Insulin | Obesity | Pancreatitis | Study